<?xml version="1.0" encoding="UTF-8"?>
<p id="par0080">Chloroquine is antimalarial and autoimmune disease drug. It blocks viral infection by increasing endosomal pH limiting virus to cell fusion as well as interfering with the glycosylation of cellular receptor ACE2 [
 <xref rid="bib0415" ref-type="bibr">83</xref>]. Hydroxychloroquine is an analog of chloroquine. Both drugs have immunomodulatory effect and can supress the immune response of IL-6 and IL-10 that have been reported to be increased in response to SARS-CoV-2 [
 <xref rid="bib0420" ref-type="bibr">84</xref>]. Clinical controlled trials have shown that chloroquine was proved to be effective in the treatment of COVID-19 by reducing pneumonia exacerbation and was included in the recommendations for the prevention and treatments of SARS-CoV-2 [
 <xref rid="bib0425" ref-type="bibr">85</xref>].
</p>
